Capital Investment Counsel, Inc
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 1418421
RALEIGH, NC
Position in HRTX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$7,821
-$6,839 QoQ
Shares Held
18,325
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#110
of 161 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Investment Counsel, Inc holds $7,821 across 1 Biotechnology name. HRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRTX |
Heron Therapeutics, Inc. /De/
This page
|
18,325 | $7,821 |
All Filings in HRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,821 | 18,325 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $14,660 | 18,325 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $23,822 | 18,325 | Shares | Sole | 2026-01-23 | |
| 2025-06-30 | $30,273 | 14,625 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $32,175 | 14,625 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $22,376 | 14,625 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $29,103 | 14,625 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $51,187 | 14,625 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $31,855 | 11,500 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $19,550 | 11,500 | Shares | Sole | 2024-02-05 | |
| No filing history on record for this holder in this stock. | ||||||